How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    References

    1. Møller JE, Engstrom T, Jensen LO et al. (2024) Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. The New England Journal of Medicine 390: 1382–93

    2. Thiele H, Møller JE, Henriques JP et al. (2024) Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up. Lancet 404: 1019–28

    3. Sassani K, Waechter C, Syntila S et al. (2025) The Role of Impella in Cardiogenic Shock Complicated by an Acute Myocardial Infarction: A Meta-Analysis. Journal of Clinical Medicine 14: 611

    4. Ardito V, Sarucanian L, Rognoni C et al. (2023) Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Comprehensive Systematic Literature Review and Meta-Analyses. Journal of Cardiovascular Development and Disease 10: 158

    5. Bogerd M, Ten Hoorn L, Ten Berg S et al. (2025) Resource utilization associated with extracorporeal membrane oxygenation vs. microaxial flow pump for infarct-related cardiogenic shock. European Heart Journal: Acute Cardiovascular Care 14: 279–87

    6. Stub D, Chan W, Ball J et al. (2025) IMPELLA COMPARED TO VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION IN CARDIOGENIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROPENSITY SCORE-MATCHED STUDIES. Shock 63: 512–19

    7. Panuccio G, Neri G, Macri LM et al. (2022) Use of Impella device in cardiogenic shock and its clinical outcomes: A systematic review and meta-analysis. International Journal of Cardiology. Heart & Vasculature 40: 101007

    8. Movahed MR, Talle A, Hashemzadeh M (2024) Intra-aortic balloon pump is associated with the lowest whereas Impella with the highest inpatient mortality and complications regardless of severity or hospital types. Cardiovascular Intervention and Therapeutics 39: 252–61

    9. Padberg J-S, Feld J, Padberg L et al. (2024) Complications and Outcomes in 39,864 Patients Receiving Standard Care Plus Mechanical Circulatory Support or Standard Care Alone for Infarct-Associated Cardiogenic Shock. Journal of Clinical Medicine 13: 1167

    10. Higuchi R, Nanasato M, Hosoya Y et al. (2024) Outcomes of Older Patients With Cardiogenic Shock Using the Impella Device - Insights From the Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD). Circulation Reports 6: 505-513